InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: runcaly post# 10999

Monday, 08/09/2021 10:09:36 PM

Monday, August 09, 2021 10:09:36 PM

Post# of 14947
The development of a Sorrento mRNA vaccine is a large undertaking. It looks like outside funding could be helpful. I see at least 3 possible routes.

1. US government funding through the DoD or DARPA. Sorrento already has growing connections with these sources.

2. Poster Sal suggested a Mexican government route.

a. Mexican president rails against big pharma, vaccines, and access...
b. Sorrento creates a fully owned subsidiary in Mexico: Sorrento Therapeutics Mexico (“Sorrento Mexico”) and INMEGEN have executed an MOU to further collaborate on clinical development of a broad pipeline of COVID products, including "diagnostics, MULTIVALENT mRNA-based VACCINES and therapeutics". Sorrento provides its most comprehensive portfolios and a “one-stop-shop" of potential solutions for governments interested in a multi-modal “detect and treat” approach to the COVID-19 pandemic.
c. Sorrento gets a Mexican Warp Speed grant from Mexico.

3. Sorrento said back on June 2,2021 that it "..is seeking major global partnership(s) to co-develop and co-commercialize Abivertinib." Abivertinib has many applications to cancers, autoimmune diseases and Covid anti-cytokine storm. Wouldn't any large pharma interested in a global partnership for Abivertinib also be interested in a second generation mRNA Covid vaccine? It is very possible. Clearly Sorrento has been working on the mRNA vaccine for at least 6 months. And global partnerships have been on the table for over 2 months.

These are 3 plausible routes. We may soon learn which path Sorrento has chosen!

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News